Assembly Biosciences, Inc. (ASMB) Operating cash flow 2016–2025
Assembly Biosciences, Inc. (ASMB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$41.1MFY2025 · since FY2016: -$34.9M → -$41.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.1M | +19.6% |
| FY2024 | -$51.1M | -324.8% |
| FY2023 | $22.7M | +126.9% |
| FY2022 | -$84.5M | +9.6% |
| FY2021 | -$93.4M | -48.3% |
| FY2020 | -$63.0M | +25.1% |
| FY2019 | -$84.1M | -29.4% |
| FY2018 | -$65.0M | -3592.4% |
| FY2017 | $1.9M | +105.3% |
| FY2016 | -$34.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice